Secretome of Human Umbilical cord mesenchymal stem cells exerts protective impacts on the blood-brain barrier against alpha-synuclein aggregates using anin vitromodel

Abstract

The blood-brain barrier (BBB) is a highly developed endothelial microvessel network extended to almost all parts of the central nervous system (CNS) that tightly seals cell-to-cell contacts and plays a critical role in maintaining CNS homeostasis. It also protects neurons from factors present in systemic circulation and prevents pathogens from entering the brain. Conversely, BBB disruption can initiate multiple pathways of nerve damage. BBB injury contributes significantly to various neurodegenerative diseases, including Parkinson's disease (PD). PD is also characterized by aggregation of the protein alpha-synuclein (αSN) to form intracellular inclusions. Recent studies have shown that due to their active secretions, mesenchymal stem cells (MSCs) can effectively relieve the severity of many neurological diseases. However, the impact of MSCs on BBB remains largely unclear. Here, we investigated the effect of Secretome extracted from MSCs on BBB when treated with toxic αSN- aggregates (αSN-AGs). For this purpose, MSCs were first isolated from Umbilical cord tissue (UC-MSC), and their secretome was collected. Then, the impact of the secretome on the cytotoxicity and inflammatory effects of αSN-AGs was examined on hCMEC/D3 cells using in vitro BBB models produced by mono- and co-culture systems. We explored the effects of αSN-AGs in the presence of UC-MSC secretome on permeability, TEER value, and cytokine/chemokine release. We found that the Secretome of UC-MSCs exerts protective effects by inhibiting the toxic effects of αSN-AGs on the BBB. These results strongly support the potential of UC-MSCs secretome for cell-free PD therapy. We also present an improved method for isolation of MSCs from umbilical cord tissue, which we hope will facilitate further studies on the use of these cells.

The impact of hUC MSC–derived exosome-nanoliposome hybrids on α-synuclein fibrillation and neurotoxicity

“…While the hUC is typically considered medical waste destined for disposal, we obtained prior consent from both parents and the hospital, following established protocols and guidelines set forth by the National Institutes of Genetic Engineering and Biotechnology Ethics Committee (IR.NIGEB.EC.1399.4.9.C). The MSC isolation procedure followed our previously established protocol using explant culture ( 72 ). Briefly, the tissue was washed two to three times with antibiotic-containing PBS.…”